Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing medications for viral skin diseases requiring medical interventions. The company’s first product candidate is an investigational drug-device combination for the topical treatment of molluscum contagiosum, a common highly contagious viral skin infection caused by a pox virus.